HIV-1 entry inhibitors and virus emergence

Comment

R T D'Aquila et al. Nat Med. 1999 Oct.

. 1999 Oct;5(10):1091.

doi: 10.1038/13385.

No abstract available

Comment in

Viral phenotype and CCR5 genotype.
Michael NL, Moore JP. Michael NL, et al. Nat Med. 1999 Dec;5(12):1330. doi: 10.1038/70878. Nat Med. 1999. PMID: 10581048 No abstract available.

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.
Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx DL, Sheppard HW. Michael NL, et al. Nat Med. 1997 Mar;3(3):338-40. doi: 10.1038/nm0397-338. Nat Med. 1997. PMID: 9055864
HIV-1 entry inhibitors: evading the issue.
Michael NL, Moore JP. Michael NL, et al. Nat Med. 1999 Jul;5(7):740-2. doi: 10.1038/10462. Nat Med. 1999. PMID: 10395316 No abstract available.